Julia Whiteker, MSN, RN

home / authors / julia-whiteker-msn-rn

Articles

Julia Whiteker Describes the ONS Breast Care SIG

Julia Whiteker Describes the ONS Breast Care SIG

Julia Whiteker, MSN, RN
May 16th 2011

Julia Whiteker Describes the ONS Breast Care SIG Online Community

Julia Whiteker on the Value of Social Media to Nurses

Julia Whiteker on the Value of Social Media to Nurses

Julia Whiteker, MSN, RN
May 13th 2011

Julia Whiteker Discusses the Value of Social Media to Oncology Nurses

Julia Whiteker on Maintaining a Social Media Community

Julia Whiteker on Maintaining a Social Media Community

Julia Whiteker, MSN, RN
May 13th 2011

Julia Whiteker from the Oncology Nursing Society Breast Care SIG on Maintaining a Social Media Community

Julia Whiteker on the ONS Breast Care SIG's Future Goals

Julia Whiteker on the ONS Breast Care SIG's Future Goals

Julia Whiteker, MSN, RN
May 12th 2011

Julia Whiteker on the Oncology Nursing Society Breast Care Special Interest Groups's Future Goals

Julia Whiteker on Guidelines for Online Communities

Julia Whiteker on Guidelines for Online Communities

Julia Whiteker, MSN, RN
May 11th 2011

Julia Whiteker on Social Media Guidelines for Online Communities

Latest Updated Articles

ASCO Offers an ‘Eye-Opening Experience’ for Nurse Practitioners
Published: June 23rd 2024 | Updated: July 27th 2024
ASCO Offers an ‘Eye-Opening Experience’ for Nurse Practitioners
Close up of hand touching smartwatch with health app on the screen, gadget for fitness active lifestyle. © sitthiphong - stock.adobe.com
Published: April 11th 2024 | Updated: July 27th 2024
Navigating Wearable Technology in Oncology Nursing While Avoiding Data Fatigue
Unlocking Bladder Cancer: A Guide to Effective Diagnosis and Staging
Published: July 11th 2023 | Updated: July 27th 2024
Unlocking Bladder Cancer: A Guide to Effective Diagnosis and Staging
Case Study: Recognizing the Typical Signs of Bladder Cancer
Published: July 11th 2023 | Updated: July 27th 2024
Case Study: Recognizing the Typical Signs of Bladder Cancer
FDA OKs Blinatumomab for Children, Adults with CD-19 B-ALL in Consolidation Phase
Published: June 14th 2024 | Updated: July 27th 2024
FDA OKs Blinatumomab for Children, Adults with CD-19 B-ALL in Consolidation Phase
With APP Help, Cancer Clinical Trials No Longer a ‘Last-Ditch’ Option
Published: April 28th 2024 | Updated: July 27th 2024
With APP Help, Cancer Clinical Trials No Longer a ‘Last-Ditch’ Option
© 2024 MJH Life Sciences

All rights reserved.